These Council reports have proposed strategies to address high and escalating prescription drug prices and costs, including promoting transparency and pharmaceutical market competition, combating anti-competitive practices, and outlining criteria for value-based pricing and prescription drug importation.
2025
- Payment for Biosimilars (PDF) CMS Report 4-I-25
- Prescription Medication Price Negotiation (PDF) CMS Report 6-A-25
- Prescription Drug Affordability Boards (PDF) CMS Report 8-A-25
- Minimum Requirements for Medication Formularies CMS Report 9-A-25
2024
- Biosimilar Coverage Structures (PDF) CMS Report 4-I-24
- Economics of Prescription Medication Prior Authorization (PDF) CMS Report 6-A-24
2023
- Prescription Drug Dispensing Policies (PDF) CMS Report 05-A-23
2022
- Parameters of Medicare Drug Price Negotiation (PDF) CMS Report 04-A-22
2021
- Access to Health Plan Information regarding Lower-Cost Prescription Options (PDF) CMS Report 2-N-21
- Continuity of Care for Patients Discharged (PDF) CMS Report 02-JUN-21
2020
- Medicare Prescription Drug and Vaccine Coverage and Payment (PDF) CMS Report 3-November 2020
- Value-Based Management of Drug Formularies (PDF) CMS Report 6-November 2020
2019
- Additional Mechanisms to Address High and Escalating Pharmaceutical Prices (PDF) CMS report 4-I-19
- The Impact of Pharmacy Benefit Managers on Patients and Physicians (PDF) CMS report 5-A-19
- Group Purchasing Organizations and Pharmacy Benefit Manager Safe Harbor (PDF) CMS report 8-A-19
2018
- Canadian Pharmacies (PDF) CMS report 1-I-18
- Insulin Affordability (PDF) CMS report 7-A-18
2016
- Access to Self-administered Medications (PDF) CMS report 4-A-16
- Medication "Brown Bagging" (PDF) CMS report 10-A-16
- Incorporating Value Into Pharmaceutical Pricing (PDF) CMS report 5-I-16
2015
- Coverage for Chronic Pain Management (PDF) CMS-CSAPH joint report A-15
- Pharmaceutical Costs (PDF) CMS report 2-I-15. Read the issue briefs for this report: Improving drug price and cost transparency (PDF) and Prescription drug pricing and costs (PDF).
- Emergency Prescription Drug Refills (PDF) CMS report 3-I-15
- Parity of Payment for Administering Biologic Medications (PDF) CMS report 4-I-15
2010
- Availability of Veterans Affairs Pharmacy Benefit (PDF) CMS report 2-A-10
2009
- Radiology Benefits Managers (PDF) CMS report 5-I-09
2008
- Payment for Biologic and Pharmacologic Agents (PDF) CMS report 3-I-08
- Comparative Effectiveness Research (PDF) CMS report 5-I-08
2007
- Maximum Allowable Cost of Prescription Medications (PDF) CMS report 2-A-07
- Cost-sharing Arrangements for Prescription Drugs (PDF) CMS report 1-I-07
Additional information
Access all council reports prior to 2007 or learn more about the Council on Medical Service.
